Monolaurin: The Antimicrobial Supplement from Coconut, What Does the Research Say?

Every few years, a supplement emerges that promises to turn coconut into a kind of natural antibiotic. One of the prominent names in this field is Monolaurin, a molecule derived from lauric acid, the same fatty acid found in coconut oil and breast milk. On social media and supplement websites, it is often presented as a universal solution against viruses, bacteria, and fungi, earning impressive nicknames like a natural shield against infections.

The real scientific story is more complex and interesting than the marketing. In a test tube, monolaurin indeed shows a remarkable ability to destroy certain bacteria and viruses, and there is a completely logical biological mechanism for this. But there is a vast gap between a laboratory petri dish and a living human body, and that is precisely where monolaurin's weak point lies. In this article, we will explain what this molecule does, how it works at the cellular level, and why our rating for it is 🟡 yellow and not 🟢 green.

What is Monolaurin?

Monolaurin, or by its scientific name glycerol monolaurate (GML), is a monoglyceride: a molecule formed by bonding lauric acid to a glycerol molecule. Here are the key points:

• It originates from lauric acid, a medium-chain fatty acid (12 carbons) abundant in coconut oil, palm kernel oil, and breast milk.
• The body itself produces a small amount of monolaurin from lauric acid, which is one reason breast milk has been attributed with antimicrobial properties.
• It is classified as a safe food additive (GRAS) by the U.S. Food and Drug Administration and has been used for many years as an emulsifier and preservative in food and cosmetics.
• It is sold as a supplement in capsules or granules, typically in doses ranging from a few hundred milligrams to several grams per day.

It is important to understand: monolaurin is not a vitamin or mineral you are deficient in, nor is it an essential nutrient. It is taken as a functional supplement with the aim of harnessing its antimicrobial activity, not to correct any nutritional deficiency.

The Connection to the Immune System: A Real Mechanism in the Test Tube

The reason monolaurin attracts scientific attention is a mechanism of action based on a simple physical property: it is an amphiphilic molecule, meaning part of it loves fat and part of it loves water. This property allows it to integrate into and disrupt fatty membranes. Here is how it works:

• Disruption of gram-positive bacterial envelopes: Monolaurin integrates into the cell membrane of bacteria like Staphylococcus aureus (staph) and Streptococcus, compromising membrane stability, thereby weakening or killing the bacterium.
• Breaking down the envelope of enveloped viruses: Many viruses, such as influenza, herpes, and CMV, are wrapped in a fatty membrane derived from the cell they infected. Monolaurin can insert into this membrane and potentially break it down, thus impairing the virus's ability to infect.
• Inhibition of toxin production: Studies have shown that even at concentrations that do not kill the bacterium, monolaurin suppresses the production of its superantigens and toxins, such as the toxin causing toxic shock syndrome.
• Prevention of biofilm: Monolaurin inhibits the formation of biofilm, the sticky protective layer bacteria create on surfaces and tissues, which makes treatment very difficult.

An important safety point: In laboratory studies, monolaurin damaged the membranes of viruses and bacteria much more than it did mammalian cells themselves. The explanation is that the lipid composition of viral membranes differs from that of body cells, making them more vulnerable. This is the reason for the substance's relatively good safety profile.

Current Evidence

Study 1: Antibacterial Activity from 2012 (Schlievert and Peterson)

One of the most cited studies in the field was published in the journal PLoS ONE in 2012 by researchers Patrick Schlievert and Marnie Peterson from the University of Minnesota. The researchers tested the antibacterial activity of monolaurin in vitro, both in liquid culture and in biofilm, against a wide range of bacteria.

The notable result: Monolaurin was at least 200 times more effective than lauric acid in destroying Staphylococcus aureus and Streptococcus pyogenes in liquid culture. Additionally, it prevented biofilm formation by Staphylococcus aureus and Haemophilus influenzae, and was even lethal within mature biofilm. This is an in vitro study, so it provides strong biological proof of concept, but it does not indicate what will happen in a human body that swallows a capsule.

Study 2: Review of Monolaurin and Lauric Acid from 2006 (Lieberman)

In 2006, Shari Lieberman, Mary Enig, and Harry Preuss published a review in the journal Alternative and Complementary Therapies that compiled the evidence on monolaurin and lauric acid as natural antiviral and antibacterial agents.

The review described activity against gram-positive bacteria (mainly Staphylococcus aureus), fungi like Candida, and enveloped viruses such as herpes simplex (HSV) and vesicular stomatitis virus (VSV). However, it is crucial to emphasize that this review is based mostly on in vitro and animal studies, not on controlled clinical trials in humans. The review is widely cited, but it does not replace strong clinical evidence.

Study 3: The Critical Review from 2020 (The Clinical Use of Monolaurin)

The most important review for a balanced understanding was published in 2020 in the Journal of Chiropractic Medicine under the title "The Clinical Use of Monolaurin as a Dietary Supplement." The researchers searched the PubMed database for real clinical evidence in humans.

The sobering finding: Out of 28 articles that appeared relevant, only 3 articles were found demonstrating an antimicrobial effect of monolaurin in humans, and all were for topical use (intravaginal and intraoral), not for oral ingestion. In other words, despite monolaurin being sold worldwide for immune support, there is almost no controlled scientific evidence that taking it orally affects infections in the body. This is precisely the reason for our 🟡 rating: the mechanism is promising, but the clinical evidence in humans is lacking.

What About Other Uses?

Many claims have been built around monolaurin that go beyond the common cold and flu. Some market it as a supportive treatment for Epstein-Barr virus (EBV), chronic fatigue, recurrent herpes, and even intestinal Candida. Some of these claims rely on the laboratory mechanism, which indeed shows activity against enveloped viruses and fungi. But double caution is needed here.

The gap between in vitro activity and clinical efficacy is the central issue. The fact that a substance kills a virus in a petri dish does not guarantee it will reach a sufficient concentration in the infected tissue after ingestion, digestion, and absorption. Most claims about EBV and chronic fatigue rely on anecdotal evidence and mechanistic reasoning, not on controlled trials. Anyone suffering from a genuine chronic condition needs diagnosis and medical treatment, not reliance on a supplement.

Should You Start Taking Monolaurin?

Several key reservations lead us to a 🟡 rating rather than 🟢:

• Human evidence is very scarce: As we saw, there are almost no controlled clinical trials examining oral intake. Most evidence comes from the lab and animal studies, and this is a fundamental difference.
• It is not a substitute for treating an active infection: If you have a significant bacterial or viral infection, monolaurin is not a medicine. Delaying real medical treatment in favor of a supplement could be dangerous.
• Lack of dosage standardization: There is no research-based uniform dosage, and products on the market vary greatly in concentration and quality.
• Possible side effects: Beyond mild digestive discomfort, some report a temporary "Herxheimer" reaction, although this is also not well documented in research.

The positive side: Monolaurin is classified as safe for consumption (GRAS), its safety profile is good, and its biological mechanism is real and well understood. It is not harmful for most healthy people, so those who want to try it as an addition during the winter season can usually do so without significant risk, as long as they understand it is a mechanism-based gamble rather than a proven treatment.

Who should be especially cautious: Pregnant and breastfeeding women, people with autoimmune diseases, and those taking regular medications should consult a doctor before use.

What to Take Away from the Research?

1. Don't expect a miracle. Monolaurin is not an antibiotic or an antiviral drug. Human evidence is scarce, so any expectation of a guaranteed effect is unfounded.
2. Never replace it with treatment for a real infection. Pneumonia, urinary tract infection, or active herpes require medical treatment. A supplement is not a substitute for diagnosis and medication.
3. If trying it, start with a low dose. Most products recommend starting with a few hundred milligrams and increasing gradually to check digestive tolerance.
4. Choose a product from a reliable brand. Since there is no strict regulation, product quality matters. Look for a brand with quality control and high-purity granules or capsules.
5. Don't neglect the basics. Adequate sleep, proper vitamin D levels, a plant-rich diet, and basic hygiene do much more for the immune system than any single supplement.

If you want to check which supplements are suitable for your health goals in a personalized way, try our personal supplement selector. For those interested in trying monolaurin from a reliable brand, you can purchase monolaurin on iHerb.

The Broader Perspective

Monolaurin is an excellent case study of the gap between a promising mechanism and clinical evidence. On one hand, here is a molecule with a real, well-understood, and well-documented biological action in the lab: it disrupts the fatty envelopes of bacteria and enveloped viruses, and it is safe for consumption. On the other hand, nearly all the evidence stops at the petri dish and the lab animal, and clinical trials in humans simply haven't been done or haven't shown clear benefit via oral intake.

This is a reminder of an important principle in the world of supplements: Impressive activity in a test tube is not a guarantee of efficacy in the body. Many substances kill viruses in a dish but fail when they need to reach an effective concentration in the right tissue, in a living body, after digestion and absorption. Monolaurin may very well be useful, but until controlled human studies are conducted, it remains in the "promising but unproven" category. And as always in this field: basics first, supplements second, and scientific truth before marketing promises.

References:
Schlievert PM, Peterson ML. Glycerol Monolaurate Antibacterial Activity in Broth and Biofilm Cultures. PLoS ONE. 2012;7(7):e40350.
Lieberman S, Enig MG, Preuss HG. A Review of Monolaurin and Lauric Acid: Natural Virucidal and Bactericidal Agents. Altern Complement Ther. 2006;12(6):310-314.
Barker LA, Bakkum BW, Chapman C. The Clinical Use of Monolaurin as a Dietary Supplement: A Review of the Literature. J Chiropr Med. 2019;18(4):305-310.